AR060264A1 - Composicion farmaceutica que contiene lactato y calcio, usos de dicha composicion y metodo de preparacion - Google Patents
Composicion farmaceutica que contiene lactato y calcio, usos de dicha composicion y metodo de preparacionInfo
- Publication number
- AR060264A1 AR060264A1 ARP070101382A ARP070101382A AR060264A1 AR 060264 A1 AR060264 A1 AR 060264A1 AR P070101382 A ARP070101382 A AR P070101382A AR P070101382 A ARP070101382 A AR P070101382A AR 060264 A1 AR060264 A1 AR 060264A1
- Authority
- AR
- Argentina
- Prior art keywords
- calcium
- per liter
- millimoles per
- pharmaceutical composition
- composition containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Composicion farmacéutica que contiene entre 250 y 5000 milimoles por litro de lactato o ácido láctico, entre 0,5 y 1,99 milimoles por litro de calcio y, opcionalmente, entre 2 y 10 milimoles por litro de potasio. La presente también se relaciona con usos farmacéuticos de esta composicion. Reivindicacion 32: Un método para preparar una composicion farmacéutica que contiene entre 250 y 5000 milimoles por litro de ácido láctico o lactato y entre 0,5 y 1,99 milimoles por litro de calcio, caracterizado porque dicho método comprende proveer las cantidades respectivas de ácido láctico o lactato de potasio y cloruro de calcio y disolver los compuestos en un solvente aceptable para uso farmacéutico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/SG2006/000083 WO2007114791A1 (en) | 2006-04-03 | 2006-04-03 | Lactate and calcium containing pharmaceutical composition and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AR060264A1 true AR060264A1 (es) | 2008-06-04 |
Family
ID=38563968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070101382A AR060264A1 (es) | 2006-04-03 | 2007-04-03 | Composicion farmaceutica que contiene lactato y calcio, usos de dicha composicion y metodo de preparacion |
Country Status (10)
Country | Link |
---|---|
US (1) | US20090285909A1 (es) |
EP (1) | EP2007371A4 (es) |
CN (1) | CN101448491A (es) |
AR (1) | AR060264A1 (es) |
AU (1) | AU2006341414A1 (es) |
BR (1) | BRPI0621528A2 (es) |
CA (1) | CA2648598A1 (es) |
MX (1) | MX2008012766A (es) |
TW (1) | TW200808305A (es) |
WO (1) | WO2007114791A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9232815B2 (en) | 2012-10-25 | 2016-01-12 | Run Them Sweet, LLC | Blood lactate range targets and nutritional formulations and protocols to support patients |
US9687011B2 (en) | 2012-10-25 | 2017-06-27 | Run Them Sweet Llc | Blood lactate range targets and nutritional formulations and protocols to support patients |
US9500657B2 (en) | 2012-10-25 | 2016-11-22 | Run Them Sweet Llc | Formulations containing labels for medical diagnostics |
US10206422B2 (en) | 2012-10-25 | 2019-02-19 | Run Them Sweet Llc | Systems and methods for monitoring of blood lactate and targeting of blood lactate via nutritional support |
KR102172971B1 (ko) * | 2012-10-25 | 2020-11-03 | 런 뎀 스위트, 엘엘씨 | 인간과 환자의 영양 요구를 측정, 평가하고 그 영양 요구의 충족을 돕는 방법 및 시스템 |
US9897609B2 (en) | 2012-10-25 | 2018-02-20 | Run Them Sweet, LLC | Systems and apparatus to estimate nutritional needs of human and other patients and to support such nutritional needs |
EP3737363A4 (en) | 2018-01-12 | 2021-10-20 | Metimedi Pharmaceuticals Co., Ltd | METHODS OF TREATMENT OF CHRONIC INFLAMMATORY DISEASES |
CN109453113A (zh) * | 2018-12-27 | 2019-03-12 | 四川太平洋药业有限责任公司 | 一种乳酸钠林格注射液生产工艺 |
EP3920846A4 (en) * | 2019-02-06 | 2022-11-09 | The Board and Trustees of the Leland Stanford Junior University | BIOLOGICALLY MODIFIED VASCULAR GRAFTS FOR IMPROVED BYPASS SURGERY RESULTS |
CN116531358A (zh) * | 2023-06-06 | 2023-08-04 | 中国医科大学附属第一医院 | 含乳酸盐缓冲体系在制备心力衰竭治疗药物中的应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987003808A1 (en) * | 1985-12-18 | 1987-07-02 | Veech Richard L | Fluid therapy with l-lactate and/or pyruvate anions |
EP0441119A3 (en) * | 1990-01-09 | 1992-10-14 | Richard D. Levere | The use of l-arginine in the treatment of hypertension and other vascular disorders |
US5248507A (en) * | 1991-05-31 | 1993-09-28 | Board Of Regents, The University Of Texas System | Hypertonic isochloremic formulation for circulatory shock |
PT701455E (pt) * | 1993-06-04 | 2001-09-27 | Biotime Inc | Solucao semelhante a plasma |
US6680305B1 (en) * | 1993-06-04 | 2004-01-20 | Biotime, Inc. | Physiologically acceptable aqueous solutions and methods for their use |
US6482853B1 (en) * | 2000-07-12 | 2002-11-19 | George A. Brooks | Lactate thiolester for cardiac energy resuscitation and prevention of reperfusion injury and use as an energy supplement during exercise and recovery |
DE10135494A1 (de) * | 2001-07-20 | 2003-11-06 | Jobst Krauskopf | Verwendung eines Lactatsalzes zur Behandlung und Prophylaxe der Athereosklerose |
BRPI0409867A (pt) * | 2003-05-01 | 2006-05-16 | Innogene Kalbiotech Pte Ltd | composição farmacêutica contendo lactato e usos da mesma |
-
2006
- 2006-04-03 AU AU2006341414A patent/AU2006341414A1/en not_active Abandoned
- 2006-04-03 US US12/295,837 patent/US20090285909A1/en not_active Abandoned
- 2006-04-03 MX MX2008012766A patent/MX2008012766A/es not_active Application Discontinuation
- 2006-04-03 CN CNA2006800547464A patent/CN101448491A/zh active Pending
- 2006-04-03 EP EP06717205A patent/EP2007371A4/en not_active Ceased
- 2006-04-03 BR BRPI0621528-9A patent/BRPI0621528A2/pt not_active IP Right Cessation
- 2006-04-03 WO PCT/SG2006/000083 patent/WO2007114791A1/en active Application Filing
- 2006-04-03 CA CA002648598A patent/CA2648598A1/en not_active Abandoned
-
2007
- 2007-03-28 TW TW096110755A patent/TW200808305A/zh unknown
- 2007-04-03 AR ARP070101382A patent/AR060264A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2007114791A1 (en) | 2007-10-11 |
MX2008012766A (es) | 2009-01-22 |
US20090285909A1 (en) | 2009-11-19 |
CA2648598A1 (en) | 2007-10-11 |
EP2007371A4 (en) | 2009-07-22 |
EP2007371A1 (en) | 2008-12-31 |
TW200808305A (en) | 2008-02-16 |
BRPI0621528A2 (pt) | 2011-12-13 |
AU2006341414A1 (en) | 2007-10-11 |
CN101448491A (zh) | 2009-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR060264A1 (es) | Composicion farmaceutica que contiene lactato y calcio, usos de dicha composicion y metodo de preparacion | |
GT200600346A (es) | Nueva fórmula cristalina v de la agomelatina, un proceso para su preparación y composiciones farmacéuticas que la contienen | |
CO6290622A2 (es) | Composiciones de activo antitranspirante con un cromatograma sec que presenta una elevada intensidad de pico 4 sec para reducir la transpiración | |
AR048878A1 (es) | Composiciones topicas de metadona y metodos para usarlas | |
CL2009001766A1 (es) | Composicion farmaceutica solida para administracion oral que comprende: un taxano sustancialmente amorfo definido, un portador hidrofilico definido y un tensoactivo definido; metodo para preparar la composicion; y su uso para tratar una enfermedad neoplasica. | |
PA8660601A1 (es) | Pirazolopiridinas y sales de las mismas, una composicion farmaceutica que comprende dichos compuestos, un metodo para prepararlos y su uso | |
CL2008003284A1 (es) | Compuestos derivados de 4-bencilamino-1-carboxiacil-piridina, inhibidores cetp; composicion farmaceutica que los comprende; combinacion farmaceutica; y uso en el tratamiento de enfermedades metabolicas, ateroesclerosis y cardiovasculares, entre otras. | |
CL2009000967A1 (es) | Compuesto 4-ciclobutil-n-((2s,5r)-5-hidroxi-2-adamantil)-2-morfolin-4-ilpiridin-5-carboxamida, inhibidor de la enzima 11betahsd1; composicion farmaceutica que lo comprende; y su uso en un procedimiento de tratamiento profilactico o terapeutico de un animal de sangre caliente. | |
ECSP078030A (es) | Formas cristalinas y otras formas de las sales de ácido láctico de 4-amino-5-fluoro-3-[6-(4-metilpiperazin -1-il)-1h-bencimidazol-2 -il]-1h-quinolin-2-ona | |
AR055076A1 (es) | Derivados de1,1-dioxido de 1,4-benzotiazepina,procedimiento para prepararlos,composiciones farmaceuticas que los contienen y usos en terapeutica. | |
AR047928A1 (es) | Derivados de tetrahidropiridoindol | |
GT200500257AA (es) | Procedimiento para producir derivados de amina opticamente activos | |
CL2008000661A1 (es) | Composiciones de sales bajas en sodio, metodos de preparacion, y uso de las mismas. | |
CO6440528A2 (es) | Composiciones adyuvantes que comprenden un agente de isotonicidad no iónico. | |
AR056268A1 (es) | Tabletas que comprenden una sustancia biologicamente activa y un excipiente | |
ECSP099563A (es) | Composiciones lubricantes personales complementarias | |
ATE485261T1 (de) | Salicylsäurederivate | |
CL2010000829A1 (es) | Metodo para tratar plantas que comprende aplicar a las plantas una composicion liquida que contiene ente 0,3 a 300 miligramos de uno o mas ciclopropenos por litro de dicha composicion. | |
AR072685A1 (es) | Composicion topica para el tratamiento de queratosis actinica | |
CL2011000147A1 (es) | Compuestos derivados de carbamato de alquiltiazol, inhibidores de la enzima faah; composicion farmaceutica que los comprende; procedimiento de preparacion de estos; y sus usos en el tratamiento de dolores agudos o cronicos, vertigo, vomitos, nauseas, epilepsias, entre otras. | |
PE20130377A1 (es) | Forma cristalina (ii) de n-benzoil-estaurosporina y procedimiento para su preparacion | |
CL2004000899A1 (es) | Composicion farmaceutica que contiene la sal sodica de telmisartan y un agente diuretico y procedimiento de preparacion. | |
ECSP11011001A (es) | Composición farmacéutica sólida | |
AR070593A1 (es) | Composiciones efervescentes | |
AR074302A1 (es) | Trans-clomifeno para el sindrome metabolico y la diabetes mellitus tipo 2.. metodo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |